PUM3 mRNA expression was ranked the third strongest predictor of olaparib sensitivity, among common significant predictors from the multivariate and univariate analyses, with increased expression correlated with increased sensitivity in multiple cancer types (Figure 2). The gene discussed is PUM3; the disease is cancer.